Sung-Eun Choi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Sung-Eun Choi has a total of 99 co-authors. Here are the top co-authors by number of shared publications:
- Beom Jin Lim
Department of Pathology, Yonsei University College of Medicine, Seoul, Republic of Korea
7 shared publications - Hyeon Joo Jeong
Department of Pathology, Yonsei University College of Medicine, Seoul, Republic of Korea
4 shared publications - Jae Il Shin
Department of Pediatrics, Yonsei University College of Medicine, Seoul, Korea
4 shared publications - Soon Won Hong
Department of Pathology, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin, Korea
4 shared publications - Sun Och Yoon
Department of Pathology, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea
3 shared publications - Ah Young Park
Department of Radiology, CHA Bundang Medical Center, CHA University, Seongnam, Republic of Korea
2 shared publications
Latest Publications
- Open Access
- 15 January 2026
- Published by The Korean Society of Pathologists and The Korean Society for Cytopathology in Journal of Pathology and Translational Medicine
- Vol. 60 (1) , 124-128
Drug-induced phospholipidosis of the kidney suspected to be caused by atomoxetine
Drug-induced phospholipidosis (DIP) is characterized by intracellular accumulation of phospholipids with lamellar body formation secondary to drug-altered lipid metabolism, which can trigger inflammation and histopathological changes. Fabry disease and DIP both exhibit zebra bodies on electron microscopy, complicating differential diagnosis. A 17-year-old male with microscopic hematuria and proteinuria had received atomoxetine (40 mg) for 11 months to treat attention-deficit hyperactivity disorder. Light microscopy showed one glomerulus with perihilar sclerosis and periglomerular fibrosis. Kidney biopsy revealed zebra bodies in podocytes, initially suggesting Fabry disease. However, α-galactosidase A enzyme activity was normal on tandem mass spectrometry. Next-generation sequencing of GLA identified only three benign variants. This represents the first reported case of atomoxetine-induced DIP. When zebra bodies are observed, clinicians should consider DIP caused by cationic amphiphilic drugs alongside Fabry disease. Atomoxetine meets the structural criteria for inducing DIP, and awareness of this potential complication is essential.
- 15 January 2026
- Published by The Korean Society of Pathologists and The Korean Society for Cytopathology in Journal of Pathology and Translational Medicine
- Vol. 60 (1) , 124-128
Open AccessDrug-induced phospholipidosis of the kidney suspected to be caused by atomoxetine
Drug-induced phospholipidosis (DIP) is characterized by intracellular accumulation of phospholipids with lamellar body formation secondary to drug-altered lipid metabolism, which can trigger inflammation and histopathological changes. Fabry disease and DIP both exhibit zebra bodies on electron microscopy, complicating differential diagnosis. A 17-year-old male with microscopic hematuria and proteinuria had received atomoxetine (40 mg) for 11 months to treat attention-deficit hyperactivity disorder. Light microscopy showed one glomerulus with perihilar sclerosis and periglomerular fibrosis. Kidney biopsy revealed zebra bodies in podocytes, initially suggesting Fabry disease. However, α-galactosidase A enzyme activity was normal on tandem mass spectrometry. Next-generation sequencing of GLA identified only three benign variants. This represents the first reported case of atomoxetine-induced DIP. When zebra bodies are observed, clinicians should consider DIP caused by cationic amphiphilic drugs alongside Fabry disease. Atomoxetine meets the structural criteria for inducing DIP, and awareness of this potential complication is essential.
- Open Access
- 31 January 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (5) , e40239
The kinetic parameters of dynamic contrast-enhanced MRI with ultrafast imaging in breast cancer patients receiving neoadjuvant chemotherapy: Prediction of pathologic complete response and correlation with histologic microvessel density
Early prediction of pathologic complete response (pCR) after neoadjuvant chemotherapy (NAC) in breast cancer patients can help forecast prognosis and guide decisions on adjuvant therapy. This study aimed to determine whether the kinetic parameters of dynamic contrast-enhanced MRI (DCE-MRI) with ultrafast imaging can predict pCR following NAC in breast cancer patients and whether these parameters are correlated with histologic microvessel density (MVD). In this retrospective study, 61 breast cancer patients who underwent NAC and surgery between August 2020 and 2022 were analyzed. Ultrafast and conventional DCE-MRI features, along with pathologic results, were compared between the pCR and non-pCR groups. Regression analysis was conducted to identify predictive factors for pCR. Additionally, MRI kinetic parameters were correlated with histologic MVD. Of the 61 patients, 17 (27.9%) achieved pCR. The pCR group exhibited a larger delayed washout component (P = .002) and a smaller angiovolume (P = .02) compared to the non-pCR group; however, these factors lost significance when accounting for tumor size, lymph node status, and molecular subtypes. In a subgroup analysis based on molecular subtype, a low initial enhancement value (≤362.5%) and angiovolume (≤10.3 cc) predicted pCR in human epidermal growth factor receptor 2-enriched breast cancer, with an area under the curve of 0.833. The maximum slope on ultrafast MRI was higher in the high MVD group compared to the low MVD group (P = .049). Human epidermal growth factor receptor 2-enriched breast cancer with low vascularity on DCE-MRI is more likely to achieve pCR, although MRI kinetic parameters were not independent predictors of pCR in all breast cancer subtypes. The maximum slope on ultrafast MRI was the only kinetic parameter that correlated with histologic MVD. Larger studies focused on molecular subtypes are warranted.
- 31 January 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (5) , e40239
Open AccessThe kinetic parameters of dynamic contrast-enhanced MRI with ultrafast imaging in breast cancer patients receiving neoadjuvant chemotherapy: Prediction of pathologic complete response and correlation with histologic microvessel density
Early prediction of pathologic complete response (pCR) after neoadjuvant chemotherapy (NAC) in breast cancer patients can help forecast prognosis and guide decisions on adjuvant therapy. This study aimed to determine whether the kinetic parameters of dynamic contrast-enhanced MRI (DCE-MRI) with ultrafast imaging can predict pCR following NAC in breast cancer patients and whether these parameters are correlated with histologic microvessel density (MVD). In this retrospective study, 61 breast cancer patients who underwent NAC and surgery between August 2020 and 2022 were analyzed. Ultrafast and conventional DCE-MRI features, along with pathologic results, were compared between the pCR and non-pCR groups. Regression analysis was conducted to identify predictive factors for pCR. Additionally, MRI kinetic parameters were correlated with histologic MVD. Of the 61 patients, 17 (27.9%) achieved pCR. The pCR group exhibited a larger delayed washout component (P = .002) and a smaller angiovolume (P = .02) compared to the non-pCR group; however, these factors lost significance when accounting for tumor size, lymph node status, and molecular subtypes. In a subgroup analysis based on molecular subtype, a low initial enhancement value (≤362.5%) and angiovolume (≤10.3 cc) predicted pCR in human epidermal growth factor receptor 2-enriched breast cancer, with an area under the curve of 0.833. The maximum slope on ultrafast MRI was higher in the high MVD group compared to the low MVD group (P = .049). Human epidermal growth factor receptor 2-enriched breast cancer with low vascularity on DCE-MRI is more likely to achieve pCR, although MRI kinetic parameters were not independent predictors of pCR in all breast cancer subtypes. The maximum slope on ultrafast MRI was the only kinetic parameter that correlated with histologic MVD. Larger studies focused on molecular subtypes are warranted.
- Open Access
- 11 December 2024
- Published by The Korean Society of Nephrology in Kidney Research and Clinical Practice
- Vol. 45 (4) , 504-515
Interobserver agreement analysis among renal pathologists in classification of lupus nephritis using a digital pathology image dataset: after a third evaluation
Lupus nephritis is well-known for low concordance in classification. Furthermore, there has been no agreement analysis among Korean renal pathologists regarding lupus nephritis. Inconsistent diagnosis leads to confusion and increases medical costs, as well as failure of appropriate therapeutic interventions. This study aimed to assess the level of agreement among Korean renal pathologists regarding classification. Representative glomerular images from patients diagnosed with lupus nephritis were obtained from five hospitals. Twenty-five questions were formulated, and multiple-choice questions with 14 options, consisting of characteristic histopathological findings of lupus nephritis were provided. Three rounds of surveys were conducted and educational sessions were conducted before the second and third surveys. The agreement was calculated using Fleiss' κ and the means for each round of questions were as follows: Survey 1, 0.42 (range, 0.18-0.61), Survey 2, 0.42 (range, 0.19-0.64), and Survey 3, 0.47 (range, 0.23-0.65). Although κ after the first education session showed no significant difference compared to the initial κ (p = 0.95), after the second education session, κ increased significantly compared to the initial κ (p < 0.001). The κ for each item generally increased with each education session, but they were not statistically significant (p = 0.46, p = 0.17). Additionally, the rankings of agreement, for each item, were relatively consistent. This study conducted an interobserver agreement analysis of Korean pathologists for lupus nephritis, with the goal of increasing agreement through education. Although the education increased overall agreement, items like "mesangial hypercellularity," "endocapillary hypercellularity," and "neutrophils and/or karyorrhexis" remained inconsistent attributable to innate subjectivity and ineffective education.
- 11 December 2024
- Published by The Korean Society of Nephrology in Kidney Research and Clinical Practice
- Vol. 45 (4) , 504-515
Open AccessInterobserver agreement analysis among renal pathologists in classification of lupus nephritis using a digital pathology image dataset: after a third evaluation
Lupus nephritis is well-known for low concordance in classification. Furthermore, there has been no agreement analysis among Korean renal pathologists regarding lupus nephritis. Inconsistent diagnosis leads to confusion and increases medical costs, as well as failure of appropriate therapeutic interventions. This study aimed to assess the level of agreement among Korean renal pathologists regarding classification. Representative glomerular images from patients diagnosed with lupus nephritis were obtained from five hospitals. Twenty-five questions were formulated, and multiple-choice questions with 14 options, consisting of characteristic histopathological findings of lupus nephritis were provided. Three rounds of surveys were conducted and educational sessions were conducted before the second and third surveys. The agreement was calculated using Fleiss' κ and the means for each round of questions were as follows: Survey 1, 0.42 (range, 0.18-0.61), Survey 2, 0.42 (range, 0.19-0.64), and Survey 3, 0.47 (range, 0.23-0.65). Although κ after the first education session showed no significant difference compared to the initial κ (p = 0.95), after the second education session, κ increased significantly compared to the initial κ (p < 0.001). The κ for each item generally increased with each education session, but they were not statistically significant (p = 0.46, p = 0.17). Additionally, the rankings of agreement, for each item, were relatively consistent. This study conducted an interobserver agreement analysis of Korean pathologists for lupus nephritis, with the goal of increasing agreement through education. Although the education increased overall agreement, items like "mesangial hypercellularity," "endocapillary hypercellularity," and "neutrophils and/or karyorrhexis" remained inconsistent attributable to innate subjectivity and ineffective education.
- Open Access
- 21 November 2023
- Published by Springer Nature in Research Square
Role of conventional dynamic contrast-enhanced MRI and ultrafast MRI in breast cancer patients receiving neoadjuvant chemotherapy: prediction of pathologic complete response and radiopathologic correlation using microvessel density
Background We investigated the potential of ultrafast MRI and conventional dynamic contrast-enhanced MRI (DCE-MRI) in predicting pathologic complete response (pCR) after neoadjuvant chemotherapy (NAC) in breast cancer patients and correlated the kinetic MRI parameters with histologic microvessel density (MVD). Methods We retrospectively analyzed 61 breast cancer patients who underwent NAC and surgery between August 2020 and August 2022. Ultrafast and conventional DCE-MRI features and pathologic results were compared between pCR and non-pCR group. Logistic regression analysis was performed to identify predictive factors for pCR. MRI kinetic parameters were correlated with histologic MVD. Results Seventeen out of 61 patients achieved pCR (27.9%). Significant differences were observed in tumor size, axillary lymph node metastasis, delayed washout component, angiovolume, and molecular subtype between pCR and non-pCR groups. Tumor size (odds ratio [OR] = .875, p = .02), axillary lymph node metastasis (OR = .032, p = .01), and HER2-enriched or triple-negative cancer types (OR = 47.530 or 751.991, p = .003 or .006) were independent predictive factors for pCR. In HER2-enriched cancer, low initial enhancement value and angiovolume were associated with pCR (p = .04). Ultrafast MRI parameters were not predictive of pCR, but maximum slope was higher in high MVD group compared to low MVD group (68.6%/sec ± 50.3 vs 40.4%/sec ± 39.3, p = .049). Conclusion Tumor size, axillary lymph node status, molecular subtypes were predictive factors for pCR in breast cancer, but ultrafast MRI parameters were not. Maximum slope on ultrafast MRI can reflect histologic MVD.
- 21 November 2023
- Published by Springer Nature in Research Square
Open AccessRole of conventional dynamic contrast-enhanced MRI and ultrafast MRI in breast cancer patients receiving neoadjuvant chemotherapy: prediction of pathologic complete response and radiopathologic correlation using microvessel density
Background We investigated the potential of ultrafast MRI and conventional dynamic contrast-enhanced MRI (DCE-MRI) in predicting pathologic complete response (pCR) after neoadjuvant chemotherapy (NAC) in breast cancer patients and correlated the kinetic MRI parameters with histologic microvessel density (MVD). Methods We retrospectively analyzed 61 breast cancer patients who underwent NAC and surgery between August 2020 and August 2022. Ultrafast and conventional DCE-MRI features and pathologic results were compared between pCR and non-pCR group. Logistic regression analysis was performed to identify predictive factors for pCR. MRI kinetic parameters were correlated with histologic MVD. Results Seventeen out of 61 patients achieved pCR (27.9%). Significant differences were observed in tumor size, axillary lymph node metastasis, delayed washout component, angiovolume, and molecular subtype between pCR and non-pCR groups. Tumor size (odds ratio [OR] = .875, p = .02), axillary lymph node metastasis (OR = .032, p = .01), and HER2-enriched or triple-negative cancer types (OR = 47.530 or 751.991, p = .003 or .006) were independent predictive factors for pCR. In HER2-enriched cancer, low initial enhancement value and angiovolume were associated with pCR (p = .04). Ultrafast MRI parameters were not predictive of pCR, but maximum slope was higher in high MVD group compared to low MVD group (68.6%/sec ± 50.3 vs 40.4%/sec ± 39.3, p = .049). Conclusion Tumor size, axillary lymph node status, molecular subtypes were predictive factors for pCR in breast cancer, but ultrafast MRI parameters were not. Maximum slope on ultrafast MRI can reflect histologic MVD.
- Open Access
- 31 March 2023
- Published by The Korean Society of Nephrology in Kidney Research and Clinical Practice
- Vol. 42 (2) , 166-173
Histologic evaluation of activity and chronicity of lupus nephritis and its clinical significance
The National Institutes of Health (NIH) lupus nephritis activity and chronicity indices, which comprise six activity scores and four chronicity scores, have a long development history. The 2018 revised International Society of Nephrology/Renal Pathology Society (ISN/RPS) classification for lupus nephritis adopted the most recent NIH indices to replace subclasses A, C, and A/C. Although an evidence-based approach should further evaluate the clinical significance of the modified NIH indices, recent validation studies demonstrated that the modified chronicity indices have a strong correlation with kidney outcome of lupus nephritis.
- 31 March 2023
- Published by The Korean Society of Nephrology in Kidney Research and Clinical Practice
- Vol. 42 (2) , 166-173
Open AccessHistologic evaluation of activity and chronicity of lupus nephritis and its clinical significance
The National Institutes of Health (NIH) lupus nephritis activity and chronicity indices, which comprise six activity scores and four chronicity scores, have a long development history. The 2018 revised International Society of Nephrology/Renal Pathology Society (ISN/RPS) classification for lupus nephritis adopted the most recent NIH indices to replace subclasses A, C, and A/C. Although an evidence-based approach should further evaluate the clinical significance of the modified NIH indices, recent validation studies demonstrated that the modified chronicity indices have a strong correlation with kidney outcome of lupus nephritis.
- Open Access
Inhibition of lysyl oxidase-like 2 ameliorates folic acid-induced renal tubulointerstitial fibrosis
Tubulointerstitial fibrosis is characterized by accumulation of the extracellular matrix in the interstitium. Lysyl oxidase-like 2 (LOXL2), a member of the lysyl oxidase family, is known for promoting cancer metastasis, invasion, and stromal fibrosis in various organs. Our previous study demonstrated expression of LOXL2 in kidney podocytes and tubular epithelial cells, and the association between elevated LOXL2 and tubulointerstitial fibrosis. The present study evaluated the effect of LOXL2 inhibition using an inhibitory monoclonal antibody (AB0023) on tubulointerstitial fibrosis in a folic acid-induced tubulointerstitial fibrosis mouse model. We also evaluated the association of LOXL2 with epithelial-mesenchymal transformation related molecules in vitro using HK-2 cells. Our data demonstrate that AB0023 prevented the progression of tubulointerstitial fibrosis significantly, as determined by trichrome and picro-sirius red staining, as well as the total collagen assay. The mean expression of phosphorylated Smad2 and Smad4 was lower in the AB0023-treated group although it was not statistically significant. Following transforming growth factor-β (TGF-β) challenge, LOXL2-deficient HK-2 cells exhibited significantly lower expression of the mesenchymal markers vimentin and fibronectin than control HK-2 cells. In conclusion, LOXL2 inhibition ameliorates renal fibrosis through the TGF-β/Smad signalling pathway.
Open AccessInhibition of lysyl oxidase-like 2 ameliorates folic acid-induced renal tubulointerstitial fibrosis
Tubulointerstitial fibrosis is characterized by accumulation of the extracellular matrix in the interstitium. Lysyl oxidase-like 2 (LOXL2), a member of the lysyl oxidase family, is known for promoting cancer metastasis, invasion, and stromal fibrosis in various organs. Our previous study demonstrated expression of LOXL2 in kidney podocytes and tubular epithelial cells, and the association between elevated LOXL2 and tubulointerstitial fibrosis. The present study evaluated the effect of LOXL2 inhibition using an inhibitory monoclonal antibody (AB0023) on tubulointerstitial fibrosis in a folic acid-induced tubulointerstitial fibrosis mouse model. We also evaluated the association of LOXL2 with epithelial-mesenchymal transformation related molecules in vitro using HK-2 cells. Our data demonstrate that AB0023 prevented the progression of tubulointerstitial fibrosis significantly, as determined by trichrome and picro-sirius red staining, as well as the total collagen assay. The mean expression of phosphorylated Smad2 and Smad4 was lower in the AB0023-treated group although it was not statistically significant. Following transforming growth factor-β (TGF-β) challenge, LOXL2-deficient HK-2 cells exhibited significantly lower expression of the mesenchymal markers vimentin and fibronectin than control HK-2 cells. In conclusion, LOXL2 inhibition ameliorates renal fibrosis through the TGF-β/Smad signalling pathway.
- Open Access
- 28 April 2020
- Published by Korean Society of Pediatric Nephrology in Childhood Kidney Diseases
- Vol. 24 (1) , 36-41
Expression of Phospholipase A2 Receptor in Pediatric Hepatitis B Virus-Related Membranous Nephropathy
Purpose: Hepatitis B virus (HBV) infection is among etiologies of secondary mem branous nephropathy (MN) in pediatric patients. We evaluated expression of phospholipase A2 receptor (PLA2R), a specific target antigen of primary MN, in pediatric HBV-related MN. Methods: We retrospectively reviewed patients with biopsy-proven HBV-related MN from the renal biopsy registry and electronic medical records of Severance Hospital, Seoul, Korea, from 1993 to 2004. Paraffin-embedded human kidney tissues were retrieved and immunohistochemically stained for PLA2R. Results: Ten pediatric patients with 13 biopsied specimens were reviewed. The predominant pathological stage was stage II-III, and second was stage II. The intensity of staining for IgG was greatest, with less intense staining for IgM, IgA, C3, C4, and C1q. All the patients had angiotensin-converting enzyme inhibitor combined with glucocorticoid, and four patients converted to cyclosporine treatment from glucocorticoid monotherapy. Urinalysis of all the patients normalized after variable period. PLA2R staining was demonstrated in the outer glomerulus in 3 out of 13 biopsies, 2 of which were obtained from the same patient over a 5-year interval. Conclusions: PLA2R was expressed in a small number of cases diagnosed as pe diatric HBV-related MN, indicating that some HBV-related MN cases may be primary MN concurrent with HBV infection.
- 28 April 2020
- Published by Korean Society of Pediatric Nephrology in Childhood Kidney Diseases
- Vol. 24 (1) , 36-41
Open AccessExpression of Phospholipase A2 Receptor in Pediatric Hepatitis B Virus-Related Membranous Nephropathy
Purpose: Hepatitis B virus (HBV) infection is among etiologies of secondary mem branous nephropathy (MN) in pediatric patients. We evaluated expression of phospholipase A2 receptor (PLA2R), a specific target antigen of primary MN, in pediatric HBV-related MN. Methods: We retrospectively reviewed patients with biopsy-proven HBV-related MN from the renal biopsy registry and electronic medical records of Severance Hospital, Seoul, Korea, from 1993 to 2004. Paraffin-embedded human kidney tissues were retrieved and immunohistochemically stained for PLA2R. Results: Ten pediatric patients with 13 biopsied specimens were reviewed. The predominant pathological stage was stage II-III, and second was stage II. The intensity of staining for IgG was greatest, with less intense staining for IgM, IgA, C3, C4, and C1q. All the patients had angiotensin-converting enzyme inhibitor combined with glucocorticoid, and four patients converted to cyclosporine treatment from glucocorticoid monotherapy. Urinalysis of all the patients normalized after variable period. PLA2R staining was demonstrated in the outer glomerulus in 3 out of 13 biopsies, 2 of which were obtained from the same patient over a 5-year interval. Conclusions: PLA2R was expressed in a small number of cases diagnosed as pe diatric HBV-related MN, indicating that some HBV-related MN cases may be primary MN concurrent with HBV infection.
- Open Access
- 20 January 2019
- Published by Wiley in BioMed Research International
- Vol. 2019, 1-10
Tubulointerstitial Infiltration of M2 Macrophages in Henoch-Schönlein Purpura Nephritis Indicates the Presence of Glomerular Crescents and Bad Clinical Parameters
Henoch-Schönlein purpura (HSP) is the most common systemic vasculitis in children, and renal involvement (HSP nephritis, HSPN) is a severe manifestation. HSPN is histologically classified by the International Study of Kidney Disease in Children (ISKDC) based on mesangial hypercellularity and the extent of glomerular crescents. Macrophages, categorized as M1 or M2, frequently infiltrate in various glomerular and tubulointerstitial diseases and infiltration of specific subtypes is associated with disease progression. Therefore, to identify whether infiltration of M1 or M2 macrophages has clinical significance, we quantified the subtypes of macrophages in 49 HSPN specimens and correlated the counts with histologic features and clinical parameters. Higher tubulointerstitial M2 counts were associated with chronic renal failure (CRF), ISKDC classes III-IV, and crescents (PP=0.036) and ISKDC classes III-IV (P=0.047). Glomerular M2 counts revealed higher AUC than glomerular M1 counts for ISKDC classes III–IV (P=0.024). Tubulointerstitial M2 counts were the most powerful parameter for CRF (AUC 0.872) and revealed even higher AUC than ISKDC classification (AUC 0.716) with borderline significance (P=0.086) for CRF. In summary, tubulointerstitial M2 counts were a superior parameter to tubulointerstitial M1 counts and even to ISKDC classification indicating the presence of CRF.
- 20 January 2019
- Published by Wiley in BioMed Research International
- Vol. 2019, 1-10
Open AccessTubulointerstitial Infiltration of M2 Macrophages in Henoch-Schönlein Purpura Nephritis Indicates the Presence of Glomerular Crescents and Bad Clinical Parameters
Henoch-Schönlein purpura (HSP) is the most common systemic vasculitis in children, and renal involvement (HSP nephritis, HSPN) is a severe manifestation. HSPN is histologically classified by the International Study of Kidney Disease in Children (ISKDC) based on mesangial hypercellularity and the extent of glomerular crescents. Macrophages, categorized as M1 or M2, frequently infiltrate in various glomerular and tubulointerstitial diseases and infiltration of specific subtypes is associated with disease progression. Therefore, to identify whether infiltration of M1 or M2 macrophages has clinical significance, we quantified the subtypes of macrophages in 49 HSPN specimens and correlated the counts with histologic features and clinical parameters. Higher tubulointerstitial M2 counts were associated with chronic renal failure (CRF), ISKDC classes III-IV, and crescents (PP=0.036) and ISKDC classes III-IV (P=0.047). Glomerular M2 counts revealed higher AUC than glomerular M1 counts for ISKDC classes III–IV (P=0.024). Tubulointerstitial M2 counts were the most powerful parameter for CRF (AUC 0.872) and revealed even higher AUC than ISKDC classification (AUC 0.716) with borderline significance (P=0.086) for CRF. In summary, tubulointerstitial M2 counts were a superior parameter to tubulointerstitial M1 counts and even to ISKDC classification indicating the presence of CRF.
- Open Access
- 15 September 2017
- Published by The Korean Society of Pathologists and The Korean Society for Cytopathology in Journal of Pathology and Translational Medicine
- Vol. 51 (5) , 463-470
The Intraoperative Immunohistochemical Staining of CD56 and CK19 Improves Surgical Decision for Thyroid Follicular Lesions
When differential diagnosis is difficult in thyroid follicular lesions with overlapping histological features, the immunohistochemical staining can help confirm the diagnosis. We aimed to evaluate the effectiveness of rapid immunohistochemical stains of CD56 and cytokeratin 19 on frozen sections of thyroid follicular lesion and explore the possible gains and limitations of the practice. Eighty-six nodules of 79 patients whose intraoperative frozen sections were selected as the control group, and 53 nodules of 48 patients whose intraoperative frozen sections were subject to rapid immunohistochemistry were selected as the study group. Five nodules (6%) in the control group were diagnosed as follicular neoplasm and six nodules (7%) were deferred. In the study group, six nodules (11%) were follicular neoplasm and none were deferred. Three nodules (4%) in the control group showed diagnostic discrepancy between the frozen and permanent diagnoses, but none in the study group. The average turnaround time for the frozen diagnosis of the control group was 24 minutes, whereas it was 54 minutes for the study group. Intraoperative rapid immunohistochemical stains significantly decreased the diagnostic discrepancy in this study. Considering the adverse effects of indefinite frozen diagnosis or discrepancy with permanent diagnoses, the intraoperative rapid immunohistochemical stain can help to accurately diagnose and hence provide guidance to surgical treatment.
- 15 September 2017
- Published by The Korean Society of Pathologists and The Korean Society for Cytopathology in Journal of Pathology and Translational Medicine
- Vol. 51 (5) , 463-470
Open AccessThe Intraoperative Immunohistochemical Staining of CD56 and CK19 Improves Surgical Decision for Thyroid Follicular Lesions
When differential diagnosis is difficult in thyroid follicular lesions with overlapping histological features, the immunohistochemical staining can help confirm the diagnosis. We aimed to evaluate the effectiveness of rapid immunohistochemical stains of CD56 and cytokeratin 19 on frozen sections of thyroid follicular lesion and explore the possible gains and limitations of the practice. Eighty-six nodules of 79 patients whose intraoperative frozen sections were selected as the control group, and 53 nodules of 48 patients whose intraoperative frozen sections were subject to rapid immunohistochemistry were selected as the study group. Five nodules (6%) in the control group were diagnosed as follicular neoplasm and six nodules (7%) were deferred. In the study group, six nodules (11%) were follicular neoplasm and none were deferred. Three nodules (4%) in the control group showed diagnostic discrepancy between the frozen and permanent diagnoses, but none in the study group. The average turnaround time for the frozen diagnosis of the control group was 24 minutes, whereas it was 54 minutes for the study group. Intraoperative rapid immunohistochemical stains significantly decreased the diagnostic discrepancy in this study. Considering the adverse effects of indefinite frozen diagnosis or discrepancy with permanent diagnoses, the intraoperative rapid immunohistochemical stain can help to accurately diagnose and hence provide guidance to surgical treatment.